Page 10 - Technology Payment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Credit: gammaCore gammaCore, a handheld device used to alleviate cluster headaches, is now availble through NHS England following successful trials. The roll out of the medical device is supported by the Medtech Funding Mandate, which fast-tracks innovations in the NHS. This mandate is part of the NHS Long Term Plan and came into effect on 1 April 2021. WHY IT MATTERS gammaCore works to relieve pain by delivering low-level electrical currents that block pain signals when held against the neck. Cluster headaches affect approximately 11,000 people in the UK, mainly men who begin experiencing t...

The market access challenge Digital health technologies are failing to reach their potential to boost the quality and efficiency of healthcare systems, largely because of a lack of dedicated access pathways or value assessment processes Digital health is an emerging and rapidly developing field with the potential to increase the quality and efficiency of healthcare systems. The rise of digital health technologies (DHTs) has been driven by an increase in non-communicable diseases and a desire by patients to take a more active role in the management of their condition and is now being accelerat...

(Photo by Tom Werner/Getty Images) Today Viz.ai, an artificial intelligence care coordination company, shared the closing of its Series C funding round worth $71 million. Scale Venture Partners and Insight Partners led the financing with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures. This latest round comes about a year and a half after its $50 million Series B raise. To date, Viz.ai has raised $150 million. WHAT IT DOES The Viz.ai platform harnesses AI to automatically review CT scans and search for suspected large vessel occl...

RapidAI Expands AI-powered Vascular Imaging Globally March 16, 2021 — RapidAI, a leader in advanced cerebrovascular imaging, announced record-shattering 2020 milestones for the company and industry, as well as an expansion of its scope into the larger vascular market. As RapidAI momentum built around the world, in addition to new products, partnerships, and awards, 2020 saw the company expand from stroke to aneurysm and lay the groundwork for other vascular diseases, both acute and non-acute. The RapidAI footprint grew to over 60 countries, with its technology utilized in over 1,800 hospi...

Teesside nurse becomes first in the world to be trained for revolutionary implant in cancer patients James Cook University Hospital nurse is leading the way on the programme Latest Teesside headlines straight to your inboxInvalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time. Thank you for...